| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $126.1M | -38.9% |
| SG&A Expense | $60.8M | -14.5% |
| Operating Income | -$186.8M | +32.6% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$176.2M | -167.7% |
| Income Tax | $20K | -39.4% |
| Net Income | -$176.2M | +32.4% |
| EPS (Basic) | -$3.35 | +32.6% |
| EPS (Diluted) | -$3.35 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $168.1M | -41.1% |
| Current Assets | $171.9M | -40.6% |
| Total Assets | $335.6M | -30.0% |
| Current Liabilities | $25.6M | -38.7% |
| Total Liabilities | $185.3M | -13.3% |
| Stockholders' Equity | $150.3M | -43.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$117.3M | +23.9% |
| Capital Expenditures | $375K | -99.1% |
| Investing Cash Flow | -$755K | -100.3% |
| Financing Cash Flow | $501K | +1516.1% |
| Free Cash Flow | -$117.7M | +39.8% |
| +32.6% |